OBJECTIVES: Alarmin high mobility group box 1 (HMGB1) is essential for correct DNA folding and transcription. It can be released from damaged cells or secreted by stimulated cells. HMGB1 has been detected in serum or plasma as a late marker of sepsis, but its suitability as a marker of sepsis has been disputed. METHODS: One-week-old germ-free piglets were orally infected/colonized with enteric bacterial pathogens (Salmonella Typhimurium or Escherichia coli O55) or with probiotic bacteria (E. coli Nissle 1917) for 24 h. The transcriptions of HMGB1, interleukin (IL)-8, tumor necrosis factor (TNF)-α, and IL-10 (quantitative reverse transcription and polymerase chain reaction), their protein levels (ELISA), and clinical state of the piglets (somnolence, anorexia, diarrhea, tachycardia, tachypnea, and tremor) were estimated. RESULTS: The piglets infected with enteric pathogens suffered from infections. HMGB1 was transcribed in the terminal ileum constitutively, regardless of any bacterial presence. In contrast, the transcription of cytokines was upregulated by virulent bacteria. HMGB1, IL-8, and TNF-α levels in the ileum were increased by both enteric pathogens, while IL-10 levels increased in E. coli O55-infected piglets only. HMGB1 significantly increased in the plasma of piglets infected with virulent E. coli only, but cytokine levels were in most cases increased by both virulent bacteria. HMGB1 and cytokine levels in ileum lavages and plasma of piglets colonized with probiotic E. coli remained comparable to those of the non-stimulated germ-free piglets. CONCLUSION: The local and systemic expression of HMGB1, its relationship to the inflammatory cytokines, and clinical findings showed HMGB1 as a suitable marker of severity of sepsis in the gnotobiotic piglet infection model.

Department of Immunology and Gnotobiology Institute of Microbiology of Academy of Sciences of Czech Republic Doly 183 549 22 Novy Hradek Czech Republic

Zobrazit více v PubMed

Crit Care Med. 2001 Jul;29(7):1303-10 PubMed

J Bacteriol. 2004 Aug;186(16):5432-41 PubMed

Crit Care. 2010;14(1):R15 PubMed

Clin Exp Immunol. 2011 Feb;163(2):242-9 PubMed

Nat Rev Immunol. 2008 Oct;8(10):776-87 PubMed

J Virol. 2006 Jan;80(1):372-82 PubMed

Folia Microbiol (Praha). 1975;20(5):433-8 PubMed

J Leukoc Biol. 2007 Jan;81(1):1-5 PubMed

Infect Immun. 2005 Sep;73(9):5514-23 PubMed

BMJ. 2007 Oct 27;335(7625):879-83 PubMed

Clin Immunol. 2005 Jan;114(1):61-9 PubMed

EMBO J. 1993 Apr;12(4):1311-9 PubMed

J Biol Chem. 2004 Oct 8;279(41):42984-92 PubMed

Mol Med. 2003 Jan-Feb;9(1-2):37-45 PubMed

Nahrung. 1987;31(5-6):507-17 PubMed

Shock. 2009 Jul;32(1):17-22 PubMed

Infect Immun. 2003 Apr;71(4):2182-91 PubMed

Science. 1999 Jul 9;285(5425):248-51 PubMed

Mediators Inflamm. 2010;2010:642462 PubMed

Vet Immunol Immunopathol. 2005 Feb 10;103(3-4):155-61 PubMed

Clin Infect Dis. 2000 Oct;31(4):851-8 PubMed

Vet Res. 2002 May-Jun;33(3):291-7 PubMed

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):296-301 PubMed

Semin Immunol. 2007 Apr;19(2):59-69 PubMed

J Cell Biol. 2007 Oct 8;179(1):33-40 PubMed

Am J Pathol. 1992 Nov;141(5):1197-207 PubMed

Nat Immunol. 2010 May;11(5):373-84 PubMed

J Bacteriol. 2002 Nov;184(21):5912-25 PubMed

Infect Immun. 1989 Apr;57(4):1142-50 PubMed

Shock. 2004 Apr;21(4):329-35 PubMed

Science. 2002 Apr 12;296(5566):301-5 PubMed

Nahrung. 1987;31(5-6):613-8 PubMed

Crit Care. 2009;13(6):R174 PubMed

Eur J Biochem. 1973 Sep 21;38(1):14-9 PubMed

Crit Care Med. 2009 Jan;37(1):291-304 PubMed

Hum Exp Toxicol. 2002 Sep-Oct;21(9-10):533-6 PubMed

Folia Microbiol (Praha). 1998;43(6):697-701 PubMed

Semin Immunopathol. 2008 Feb;30(1):29-40 PubMed

J Crit Care. 2008 Dec;23(4):455-60 PubMed

Chest. 1992 Jun;101(6):1644-55 PubMed

Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):149-56 PubMed

Pediatr Res. 2005 Aug;58(2):309-14 PubMed

Dev Comp Immunol. 2009 Mar;33(3):267-72 PubMed

Crit Care Med. 2009 Jul;37(7):2290-8 PubMed

FASEB J. 2010 Mar;24(3):712-22 PubMed

Shock. 2008 Oct;30 Suppl 1:53-9 PubMed

Shock. 2010 Jun;33(6):562-7 PubMed

Scand J Immunol. 2008 Jul;68(1):75-84 PubMed

J Endotoxin Res. 2003;9(6):367-74 PubMed

Scand J Immunol. 2009 Jun;69(6):479-91 PubMed

Nat Genet. 1999 Jul;22(3):276-80 PubMed

Vet Immunol Immunopathol. 2006 Jun 15;111(3-4):199-209 PubMed

Nature. 2002 Jul 11;418(6894):191-5 PubMed

Shock. 2009 Sep;32(3):302-9 PubMed

Shock. 2009 Dec;32(6):586-92 PubMed

Intensive Care Med. 2010 Dec;36(12):2132-9 PubMed

Crit Care Med. 2007 Apr;35(4):1061-7 PubMed

Commensal Bacteria Impact on Intestinal Toll-like Receptor Signaling in Salmonella-Challenged Gnotobiotic Piglets

Release of HMGB1 and Toll-like Receptors 2, 4, and 9 Signaling Are Modulated by Bifidobacterium animalis subsp. lactis BB-12 and Salmonella Typhimurium in a Gnotobiotic Piglet Model of Preterm Infants

High Mobility Group Box 1 in Pig Amniotic Membrane Experimentally Infected with E. coli O55

Toll-Like Receptor 4 Signaling in the Ileum and Colon of Gnotobiotic Piglets Infected with Salmonella Typhimurium or Its Isogenic ∆rfa Mutants

High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with L. amylovorus, L. mucosae, E. coli Nissle 1917 and S. Typhimurium

Impact of the Lipopolysaccharide Chemotype of Salmonella Enterica Serovar Typhimurium on Virulence in Gnotobiotic Piglets

Colonization of Germ-Free Piglets with Commensal Lactobacillus amylovorus, Lactobacillus mucosae, and Probiotic E. coli Nissle 1917 and Their Interference with Salmonella Typhimurium

Colonization of preterm gnotobiotic piglets with probiotic Lactobacillus rhamnosus GG and its interference with Salmonella Typhimurium

Preterm Life in Sterile Conditions: A Study on Preterm, Germ-Free Piglets